HilleVax, Inc., (HLVX): Price and Financial Metrics Recent IPO
GET POWR RATINGS... FREE!
HLVX Stock Price Chart Interactive Chart >
HLVX Price/Volume Stats
| Current price | $13.17 | 52-week high | $20.95 |
| Prev. close | $13.32 | 52-week low | $7.90 |
| Day low | $12.69 | Volume | 19,059 |
| Day high | $13.70 | Avg. volume | 165,278 |
| 50-day MA | $11.53 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 440.23M |
HilleVax, Inc., (HLVX) Company Bio
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
HLVX Price Returns
| 1-mo | -4.57% |
| 3-mo | -1.94% |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...